FAQ-4 19- What Chance Stem Cells Can Help Me After Stem Cell Therapy? youtu.be Whether differentiated or undifferentiated, from sheep stem cells or from rabbit; delivered frozen or fresh, today's stem cell therapies are showing real promise and helping HIV-AIDS sufferers around the world, today! Cautious not to claim they can cure ANYTHING, today's ethical clinics offer hope for AIDS-HIV sufferers worldwide, although the one Thai clinic licensed by the German stem cell technique is in Bangkok. For information to help you make an informed, personal decision, check out StemCell-Asia.info today.From:Harvey WallbangerViews:0 0ratingsTime:01:38More inPeople Blogs See more here: FAQ-4 19- What Chance Stem Cells Can Help Me After Stem Cell Therapy? - Video … Continue reading →

FAQ-4 19- What Chances for Stem Cell Success When I Get Stem Cell Therapy? youtu.be Whether as differentiated or undifferentiated, whether from sheep stem cells or from rabbit stem cells; delivered frozen or fresh, today's stem cell therapies are showing real promise and helping HIV-AIDS sufferers around the world, today! Cautious not to claim they can cure ANYTHING, today's ethical clinics offer hope for AIDS-HIV sufferers worldwide, although the one Thai clinic licensed by the German stem cell technique is in Bangkok. For information to help you make an informed, personal decision, check out StemCell-Asia.info today.From:VeteransRecallViews:0 0ratingsTime:01:38More inPeople Blogs The rest is here: FAQ-4 19- What Chances for Stem Cell Success When I Get Stem Cell Therapy? - Video … Continue reading →

Dave Kekich The Bridge to Longevity Scientists have the research and many of the answers to help millions of people suffering from chronic pain, disability and degenerative diseases associated with aging. They need your support to prove a therapy that utilizes a patient's own adult stem cells to rejuvenate their body.From:CentagenViews:6 0ratingsTime:01:40More inScience Technology Link: Dave Kekich The Bridge to Longevity - Video … Continue reading →

SAN DIEGO--(BUSINESS WIRE)-- Cytori Therapeutics (CYTX) today announced two independent investigator-sponsored and funded cell therapy clinical studies in Japan have been approved by the Ministry of Health, Labor and Welfare under the Guidelines on Clinical Research Using Human Stem Cells. One study will investigate the use of Cytoris cell therapy as a treatment for ischemic heart failure and the other as a treatment for cirrhosis of the liver. The studies will be performed by Shuichi Kaneko, M.D., Ph.D., Professor and Chairman of Departments of Gastroenterology, and Disease Control and Hemostasis, Graduate School of Medicine at Kanazawa University Hospital School of Medicine. In each study, patients will receive an injection of Cytoris cell therapy, which consists of their own adipose-derived stem and regenerative cells (ADRCs) processed at the point-of-care using the Cytoris proprietary and automated Celution System. The ischemic heart failure study will enroll patients with low left ventricular function due to a prior heart attack and the ADRCs will be delivered through the coronary artery. In the study of patients with cirrhosis of the liver, the ADRCs will be delivered through the hepatic artery. About Cytori Cytori Therapeutics, Inc. is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) … Continue reading →

NEW YORK (AP) Biotechnology company BioTime Inc. on Thursday proposed two transactions that would combine its stem cell therapy assets with those of Geron Corp. In a letter to Geron shareholders, BioTime suggests two deals that would form a new publicly traded company owning Geron's stem cell assets with some of BioTime's. It said Geron could have a stake of up to 45 percent in the company, which would also hold $40 million in BioTime stock along with shares of some BioTime stem cell subsidiaries. Geron shareholders would also receive BioTime stock-purchase warrants now valued at about $13 million. Geron, of Menlo Park, Calif., was a pioneering developer of stem cell therapies. But in November 2011 it said it would exit that business and focus on development of other products, including its experimental cancer drug imetelstat. "Nearly a year has now passed, and Geron has not announced any transaction that would provide value to either Geron or its shareholders from those stem cell assets," BioTime said in a press release. The Alameda, Calif., company said Geron shareholders should contact the board of directors and urge the company to have discussions with BioTime. Geron did not immediately respond to a request … Continue reading →

MANILA, Philippines Amid the recent warning issued by the Department of Health (DOH) regarding stem cell therapy, doctors who are offering the treatment in the Philippines clarified that they are not promising a cure. We are very careful about claiming cure. These days ang dami nagsasalita, nawala ang sakit. All of a sudden siya (stem cell therapy) na yung magic bullet ng buong mundo, like if you get stem cell, you get cured, said Dr. Michelle de Vera, deputy director of the Institute of Personalized Molecular Medicine at The Medical City. Kapag may narinig na ganyan dapat lalo silang mag-ingat. Cure is zero evidence of disease or kung genetic yung disease dapat napalitan yung genes mo. Hindi mangyayari yun at this point," he stressed. De Vera, an allergologist and immunologist, does stem cell therapy on her patients at The Medical City but he said he believes that the DOH is right in warning patients on stem cell therapy. Tama naman na magbigay sila ng warning,I think what their trying to do is regulate stem cell therapy, the doctor said. Public advisory The DOH recently came out with a public advisory on stem cell therapies saying that there is an "observed … Continue reading →

San Diego, CA/PRNewswire/ - ViaCyte, Inc., a leading regenerative medicine company developing a transformative cell therapy for treatment of diabetes, announced today that it has received a$10.1 millionStrategic Partnership Award from the California Institute for Regenerative Medicine (CIRM). ViaCyte's innovative stem cell-based therapy for diabetes has been supported by several previous rounds of funding from CIRM, including a$20 millionDisease Team Award in 2009. This support has directly aided the development of VC-01, a regenerative medicine, combination product consisting of pancreatic beta cell progenitors encapsulated in a durable macroencapsulation device. When implanted under the skin of a patient with diabetes, VC-01 is expected to produce insulin and other factors which should safely and effectively control their disease. In its review of ViaCyte's application, CIRM's Grants Working Group characterized the Company's proposed therapy as the "holy grail" of diabetes treatments. ViaCyte recently held a successful Pre-IND meeting with the United States Food and Drug Administration (FDA) and is on track to file an Investigational New Drug (IND) Application and initiate clinical evaluation of VC-01 in 2014. The Strategic Partnership Award from CIRM will be used to support these efforts, reflecting CIRM's commitment to following promising science through the progressive stages of product … Continue reading →

MANILA, Philippines - Hindi umano dapat na katakutan ng publiko ang stem cell therapy. Ito ang nilinaw nina Dr. Jim de Castro at Dr. Frankling Domingo, na nagpakadalubhasa sa stem cell therapy sa Harvard University sa ginanap na Balitaan sa Tinapayan. Ayon kay Dr. Domingo, walang panganib sa stem cell therapy na ngayon ay ginagamit na pangunahing medisina sa Estados Unidos. Anila, galing mismo sa pasyente ang stem cell therapy na kinukuha nila mula sa bone marrow, dugo at fats na kanilang ini-inject sa masakit na bahagi ng katawan ng pasyente gaya ng tuhod at iba pa na dulot ng arthritis. Sinabi ni Dr. de Castro na marami na ang sumusubok sa nasabing therapy dahil sa paniniwalang mas madali ang gamutan nito at mas matipid. Ngunit pinapayuhan ni de Castro ang publiko na mas mabuting panatilihing maging malusog ang pangangatawan,walang bisyo upang maging maganda ang kalalabasan ng isasagawang stem cell therapy kapag malinis ang dugong makukuha na siya ring ituturok sa katawan ng isang pasyente. Una nang nanawagan si Health Secretary Enri que Ona sa publiko na ipagpaliban muna ang mga ine-schedule nilang pagpapasailalim ng stem cell therapy, lalot hindi alam kung anong proseso ang ginagawa sa naturang therapy, lalo … Continue reading →

Gov. Rick Perry pushed Friday for Texas to become the center of adult stem-cell therapy, disregarding the federal government's increasing crackdown on clinics marketing the experimental medicine. Perry told a crowd of stem-cell researchers, industry leaders and patients gathered in Houston that the young science "holds the promise of miracles" desperately needed by people across the world and suggested Texas' "wildcat spirit" and "conducive climate" can make it happen here. "I'm not shy about asking people to relocate or start up their companies in Texas," said Perry, likening stem-cell treatment to previous innovations in space and heart care. "All of you outside the state of Texas - come on in. The water's fine. We've got an amazing environment here." Perry, who famously got the unlicensed treatment for an ailing back in 2011, said the state has made sure that innovators won't be "hindered by exorbitant taxes, wrapped up by bureaucratic red tape or at the mercy of predatory attorneys, seeking to make steady money off extensive, drawn-out court cases." Perry's remarks, made at the first of a planned annual Houston conference, came as the state appears headed toward a collision with the Food and Drug Administration, which has begun stepping … Continue reading →

By Erika Sauler Philippine Daily Inquirer MANILA, Philippines This type of stem cell therapy does not claim to be the fountain of youth, but an alternative treatment to arthritis, muscle pain and tendon tear. Two Filipino doctors who trained in the United States said in a media forum on Sunday that autologous stem cell therapy could speed up the healing of musculoskeletal and sports-related injuries, which could be an optional remedy before undergoing surgery. Dr. Jeimylo de Castro explained that the procedure would involve taking stem cells from the patients blood, fat tissue or bone marrow and injecting them to the injured area of the same person. This type of therapy is different from the controversial embryonic stem cells which are harvested from animals or fertilized eggs. With stem cell therapy being a current fad for anti-aging, the Department of Health has warned the public that the benefits of stem cell therapy are still under evaluation. The DOH will soon issue guidelines for the use of stem cell therapy and the licensing of facilities offering this service. De Castro and Dr. Franklin Domingo are both fellows of the Philippine Academy of Rehabilitation Medicine. They underwent training for stem cell therapy … Continue reading →